U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734870) titled 'Tirzepatide for Treatment of CCCA' on July 24.
Brief Summary: The goal of this pilot clinical trial is to learn if tirzepatide can treat active central centrifugal cicatricial alopecia (CCCA), a type of permanent scarring hair loss, in adults. The main questions it aims to answer are:
* Does tirzepatide improve the symptoms and signs of active CCCA?
* Does tirzepatide change the activity of genes in the scalp, especially genes related to scarring?
* Does tirzepatide promote hair regrowth?
Participants will:
* Inject tirzepatide once a week for 12 months.
* Visit the clinic for scalp examinations, photographs, and other health ...